For years, people on antidepressants were told to avoid microdosing. It was widely accepted that SSRIs and other psychiatric medications could interfere with the effects of psychedelics. In some cases, the combination was considered dangerous. But is that still true?
Not exactly. Emerging studies and real-world data are beginning to show a very different picture—one that invites more nuance, more safety, and ultimately, more access.
The Old View: Caution First
Traditional thinking warned against mixing antidepressants with psychedelics. Most of this concern came from high-dose ceremonial or clinical use, where medications like MAOIs or SSRIs could affect serotonin levels dangerously. The fear was serotonin syndrome—a rare but serious condition caused by too much serotonin in the brain.
Because of this risk, even microdoses (which are sub-perceptual and much smaller than full doses) were lumped into the same category. Many people self-excluded. Practitioners turned them away. Protocols marked SSRIs as an automatic no.
What the New Studies Are Saying
Recent data suggests that microdosing may not carry the same risk profile as full-dose psychedelic experiences.
A 2020 observational study by Polito & Liknaitzky tracked microdosing individuals, including those on antidepressants. It showed that many participants still reported improved mood, focus, and emotional well-being—without adverse events.
A 2022 survey conducted by the Beckley Foundation found that individuals on SSRIs who also microdosed experienced similar benefits to those not on medication. Their data did not show a higher incidence of negative effects.
Several clinicians working in integrative psychiatry have also noted that microdosing does not appear to cause serotonin syndrome when combined with standard antidepressants, especially when doses are low and spaced apart appropriately.
Real-World Experience Is Adding to the Evidence
A growing number of therapists, coaches, and facilitators are observing similar patterns: people on SSRIs or SNRIs who microdose under guidance often tolerate the practice well. The effects may be slightly muted in some cases, but many still feel more emotionally balanced, motivated, or connected.
That doesn’t mean everyone reacts the same. People respond to both medications and microdoses differently. But the blanket rule—no microdosing if you’re on antidepressants—no longer holds the weight it once did.
What This Means for You
If you are currently taking antidepressants and have been curious about microdosing, know that the door isn’t automatically closed. Many people in your situation are exploring microdosing with support, education, and intention—and doing so safely.
It’s still important to:
- Work with someone who understands both medicines and microdosing.
- Start low, go slow.
- Track your experience carefully.
- Stay in communication with your healthcare provider.
Final Thoughts
Science is catching up with lived experience. The outdated idea that antidepressants and microdosing never mix is shifting. As we learn more, safer paths are becoming visible—especially for those looking for alternative ways to feel better, function more fully, or simply feel like themselves again.
At Grassroots Microdose, we believe in informed choices, ongoing learning, and supporting you where you’re at. Microdosing is not one-size-fits-all. But for many, it no longer needs to be off-limits.